GlassScriptPhysician profile
Bingtao Lin
NPI 1407277155
$6,854.73
in general payments reported to CMS, 2019-2025
38 companies · $675 in 2025
The $675 reported for 2025 was more than what a typical Pain Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $400).
See the full distribution for Pain Medicine (Physical Medicine & Rehabilitation)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $751 · 2020: $151 · 2021: $632 · 2022: $2,189 · 2023: $1,697 · 2024: $760 · 2025: $675.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,132.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,131.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,837.24 | 2022-2025 | |
| Medtronic, INC. | $1,022.07 | 2022-2024 | Intellis Adaptivestim, Accurian |
| Stimwave Technologies Incorporated | $493.35 | 2019-2022 | |
| Scilex Pharmaceuticals INC. | $313.98 | 2021-2024 | Ztlido |
| Collegium Pharmaceutical, INC. | $303.91 | 2019-2024 | Belbuca, Xtampza |
| Spr Therapeutics, INC | $299.24 | 2021-2024 | Sprint Pns System |
| Zyla Life Sciences, INC. | $252.95 | 2019-2020 | |
| Biohaven Pharmaceutical Holding Company LTD. | $234.25 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $189.55 | 2021 | |
| Amgen INC. | $169.31 | 2021-2023 | Prolia, Evenity |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $147.96 | 2022-2025 | Relistor |
| Abbott Laboratories | $140.38 | 2019-2025 | Proclaim |
| Novo Nordisk INC | $140.33 | 2025 | Ozempic, Rybelsus |
| Nevro Corp. | $130.69 | 2019-2022 | |
| Pfizer INC. | $127.32 | 2021-2024 |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Curonix LLC | $126.58 | 2023 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Bayer Healthcare Pharmaceuticals INC. | $101.24 | 2025 | |
| Vertex Pharmaceuticals Incorporated | $100.58 | 2024-2025 | |
| Boston Scientific Corporation | $99.05 | 2022-2024 | Wavewriter Alpha Prime 16, Infinion 16 |
| Grt US Holding, INC. | $96.36 | 2022 | |
| Allergan, INC. | $93.08 | 2021-2022 | |
| Merz Pharmaceuticals, LLC | $59.38 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $49.08 | 2019 | |
| Bioventus LLC | $41.06 | 2021-2023 | Durolane |
| Forte Bio-Pharma LLC | $40.14 | 2022-2024 | Prolate, Nalocet |
| Merz North America, INC. | $28.30 | 2019-2020 | |
| Lilly USA, LLC | $25.92 | 2025 | Mounjaro, Zepbound |
| Fidia Pharma USA INC. | $23.39 | 2022 | |
| Ibsa Pharma INC. | $21.16 | 2024 | Flector, Licart, Tirosint |
| Ardelyx, INC. | $20.82 | 2025 | Ibsrela |
| Mdd US Operations, LLC | $20.52 | 2019 | |
| Biodelivery Sciences International, INC. | $16.84 | 2021 | |
| Hikma Pharmaceuticals USA | $16.70 | 2022 | |
| Vertos Medical, INC. | $14.92 | 2022 | |
| Cranial Technologies, INC | $14.92 | 2025 | Doc Band |
| Daiichi Sankyo INC. | $14.53 | 2019 | |
| Depuy Synthes Sales INC. | $14.17 | 2022 | |
| Avanos Medical | $13.46 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bingtao Lin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.